Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Infections 3Neutropenia 2Soft Tissue Infections 1Lymphoma, Follicular 1Hot Flashes 1Hematologic Neoplasms 1Fournier Gangrene 1Fever 1Fasciitis, Necrotizing 1

Interventions

Vancomycin 4pegfilgrastim 3Cefepime 3trametinib 2liposomal amphotericin B 2dabrafenib 2Piperacillin, Tazobactam Drug Combination 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Caspofungin 2ofatumumab 1ceftobiprole medocaril 1Teicoplanin 1Tazobactam 1Surveys and Questionnaires 1Ritonavir 1Quality of Life 1Povidone-Iodine 1Piperacillin 1Moxifloxacin 1Metformin 1Mannose-Binding Lectin 1Levofloxacin 1Lenalidomide 1Itraconazole 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fever × Daptomycin × Clear all
NCT00335478 2017-05-09

Daptomycin in Treating Neutropenia and Fever in Patients With Cancer

OHSU Knight Cancer Institute

Phase 2 Completed
54 enrolled 4 charts

Fever, Infections, Neutropenia, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡